Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.2
-1.64 %
$ 15.5 M
Market Cap
1.41
P/E
EGRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities EGRX - Eagle Pharmaceuticals, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR